MOH Stock Analysis: Buy, Sell, or Hold?

MOH - Molina Healthcare, Inc.

HOSPITAL & MEDICAL SERVICE PLANS
$139.38
3.56 (2.62%) ▲
5d: +0.42%
30d: -7.1%
90d: -19.68%
BUY
HIGH Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: Apr 22, 2026 18d
Smart Money Accumulation

MOH is down 4.2% this week, but smart money is accumulating calls. Top strike: $170 2026-04-17 with 228 OI. Call ratio: 64% View Scanner →

Strength: 3.5/10

Get Alerted When MOH Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: MOH shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$117.53
Based on 4.1% avg growth
INTRINSIC VALUE TODAY
$72.98
Trading above fair value

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.7x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: MOH is currently trading at $139.38, which is considered slightly low relative to its 30-day fair value range of $137.71 to $150.07. From a valuation perspective, the stock is trading at a premium (Forward PE: 24.1) compared to its historical average (16.7). At these levels, the market is pricing in 13.0% annual earnings growth.

Technical Outlook: Technically, MOH is in a strong downtrend. Immediate support is located at $131.20, while resistance sits at $144.31.

Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position SLIGHTLY LOW
Fair Price Range $137.71 - $150.07
Company Quality Score 54/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 78.1%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Mixed technical signals (45/100)
  • BULLISH: High volume confirmation
  • NEUTRAL: Near Wall St target ($150.65)
  • BULLISH: Expecting earnings turnaround to 13.0% growth with 7.1% revenue growth

Fair Price Analysis

30-Day Fair Range $137.71 - $150.07
Current vs Fair Value SLIGHTLY LOW

Support & Resistance Levels

Support Level $131.20
Resistance Level $144.31
Current Trend Strong Downtrend
Technical data as of Apr 2, 2026

Fundamental Context

Forward P/E (Next Year Est.) 24.15
Wall Street Target $150.65 (+8.1%)
Revenue Growth (YoY) 7.1%
Earnings Growth (YoY) -73.4%
Profit Margin 1.1%
Valuation Premium vs History +13.0% premium
PE vs Historical 24.2 vs 16.7 STRETCHED
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +13.0% (market-implied from PE analysis)
1-Year Target $157.50 (+13%)
2-Year Target $177.97 (+28%)
3-Year Target $201.11 (+44%)
3-Yr Target (if PE normalizes) (PE: 24→17) PE COMPRESSION $139.05 (0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 24.2, Growth: 4.1%) $157.39 (+13%)
Base: (SPY PE: 20.6, Growth: 4.1%) $134.04 (-4%)
Bear: (PE: 16.7, Growth: 4.1%) $108.82 (-22%)
📈 Valuation based on Current Earnings
Trailing PE: 15.63 | Current EPS (TTM): $8.92
Bull Case $99.21 (-27%)
Analyst growth -35.3%, PE expands to 17.2
Base Case $90.19 (-33%)
Market implied -35.3%, PE stable at 15.6
Bear Case $94.80 (-30%)
Severe decline -20.0%, PE contracts to 13.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: April 03, 2026 2:29 AM ET
Data refreshes hourly during market hours. Next update: 3:29 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
2
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna BUY 2026-02-24
Ro Khanna SELL 2026-02-17
Ro Khanna SELL 2026-02-05

Unlock Insider Activity

See real-time buying/selling by company executives for MOH.

Create Free Account

Already have an account? Log In

Top Rated Healthcare Plans Stocks

Top-rated stocks in Healthcare Plans by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
CVS
CVS Health Corp
STRONG BUY
28 analysts
$97 63 BUY
UNH
UnitedHealth Group Incor…
STRONG BUY
27 analysts
$361 64 BUY
CI
Cigna Corp
STRONG BUY
25 analysts
$339 61 BUY
ELV
Elevance Health Inc
STRONG BUY
22 analysts
$381 58 HOLD
HUM
Humana Inc
HOLD
26 analysts
$212 57 HOLD

Advanced MOH Option Strategies

Professional options setups generated by AI based on today's MOH price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for MOH

MOH Technical Chart MOH Price Prediction MOH Earnings Date MOH Investment Advisor MOH Fair Price Analyzer MOH Options Advisor MOH Options Chain MOH Options Analysis MOH Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals